Standout Papers

Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic R... 1998 2026 2007 2016 728
  1. Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma (1998)
    Sylvie Négrier, Bernard Escudier et al. New England Journal of Medicine

Immediate Impact

3 by Nobel laureates 8 from Science/Nature 67 standout
Sub-graph 1 of 17

Citing Papers

Naturally occurring T cell mutations enhance engineered T cell therapies
2024 StandoutNature
Tertiary lymphoid structures in cancer
2022 StandoutScience
2 intermediate papers

Works of A. Mercatello being referenced

Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma
1998 Standout

Author Peers

Author Last Decade Papers Cites
A. Mercatello 271 693 607 455 60 1.5k
Ioannis Kalomenidis 362 1182 314 293 87 2.0k
Weidong Hu 126 447 435 524 42 1.8k
Shruti Agrawal 151 530 816 242 70 1.9k
Elisabetta Balestro 137 1129 232 328 87 1.9k
Raj S. Kasthuri 290 312 249 551 68 2.2k
Sow-Hsong Kuo 337 1114 428 417 66 2.1k
William D. Hardie 331 1446 235 536 68 2.3k
Seung Soo Yoo 165 615 345 568 148 1.6k
Yongbo Huang 138 333 184 799 61 1.5k
Manousos M. Konstadoulakis 733 538 363 269 79 1.8k

All Works

Loading papers...

Rankless by CCL
2026